Joachim Widder

  1. Induction of pulmonary hypertension may explain early mortality after thoracic radiotherapy

    Van Luijk, P., Gorter, T. M., Willems, T. P., Coppes, R. P., Widder, J. & Langendijk, J. A., 1-May-2017, In : Radiotherapy and Oncology. 123, p. S67-S68 2 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  2. External validation of NTCP models for pneumonitis in lung cancer patients receiving proton therapy

    Niezink, A., Jain, V., Chouvalova, O., Wijsman, R., Muijs, C., Frick, M., Doucette, A., Simone, C., Chinniah, C., Widder, J., Langendijk, J., Van der Schaaf, A. & Berman, A., Apr-2019, In : Radiotherapy and Oncology. 133, p. S404-S405 2 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  3. Thoracic tumor treatment course assessment based on 4D dose accumulation for scanned proton therapy

    Meijers, A., Richter, C., Dessy, F., Widder, J., Korevaar, E., Jacobi, A., Ribeiro, C. O., Langendijk, J. A. & Knopf, A., 2017.

    Research output: Contribution to conferenceAbstractAcademic

  4. Population-based Results of Chemoradiotherapy for Limited Stage Small Cell Lung Cancer in The Netherlands

    Damhuis, R., Widder, J. & Senan, S., Jan-2018, In : Clinical Oncology. 30, 1, p. 17-22 6 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (71) »

ID: 440422